162 related articles for article (PubMed ID: 25104791)
21. The role of operations for distantly metastatic well-differentiated thyroid carcinoma.
Stojadinovic A; Shoup M; Ghossein RA; Nissan A; Brennan MF; Shah JP; Shaha AR
Surgery; 2002 Jun; 131(6):636-43. PubMed ID: 12075176
[TBL] [Abstract][Full Text] [Related]
22. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
23. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Factors in Patients with Differentiated Thyroid Cancers Metastatic to the Cervical Spine.
Yin LX; Puccinelli CL; Van Abel K; Kasperbauer JL; Price DL; Janus JR; Ryder M; Moore EJ
Laryngoscope; 2021 May; 131(5):E1741-E1747. PubMed ID: 33095932
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results.
Niederle B; Roka R; Schemper M; Fritsch A; Weissel M; Ramach W
Surgery; 1986 Dec; 100(6):1088-97. PubMed ID: 3787464
[TBL] [Abstract][Full Text] [Related]
27. Metastatic site discriminates survival benefit of primary tumor surgery for differentiated thyroid cancer with distant metastases: A real-world observational study.
Ding W; Ruan G; Zhu J; Tu C; Li Z
Medicine (Baltimore); 2020 Nov; 99(48):e23132. PubMed ID: 33235073
[TBL] [Abstract][Full Text] [Related]
28. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
29. Death from differentiated thyroid carcinoma: retrospective study of a 40-year investigation.
Ronga G; Filesi M; Montesano T; Melacrinis FF; Di Nicola A; Ventroni G; Antonaci A; Vestri AR
Cancer Biother Radiopharm; 2002 Oct; 17(5):507-14. PubMed ID: 12470420
[TBL] [Abstract][Full Text] [Related]
30. Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.
Hong YW; Lin JD; Yu MC; Hsu CC; Lin YS
Int J Surg; 2018 Jul; 55():182-187. PubMed ID: 29883619
[TBL] [Abstract][Full Text] [Related]
31. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.
Wang LY; Palmer FL; Nixon IJ; Thomas D; Patel SG; Shaha AR; Shah JP; Tuttle RM; Ganly I
Thyroid; 2014 Nov; 24(11):1594-9. PubMed ID: 25162180
[TBL] [Abstract][Full Text] [Related]
32. Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
Kondraciuk JD; Rice SL; Zhou X; Gharzeddine K; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK; Osborne JR
Clin Nucl Med; 2019 Aug; 44(8):e465-e471. PubMed ID: 31274625
[TBL] [Abstract][Full Text] [Related]
33. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
Mihailovic J; Stefanovic L; Malesevic M; Markoski B
Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
[TBL] [Abstract][Full Text] [Related]
34. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
35. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
36. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer.
Ishigaki T; Uruno T; Sugino K; Masaki C; Akaishi J; Hames KY; Suzuki A; Tomoda C; Matsuzu K; Ohkuwa K; Kitagawa W; Nagahama M; Miyazaki S; Ito K
J Radiat Res; 2019 Nov; 60(6):831-836. PubMed ID: 31423531
[TBL] [Abstract][Full Text] [Related]
38. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma.
Choi YM; Kim WG; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Hong EG; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2016 Sep; 175(3):165-72. PubMed ID: 27272238
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
40. Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome.
Hindié E; Zanotti-Fregonara P; Keller I; Duron F; Devaux JY; Calzada-Nocaudie M; Sarfati E; Moretti JL; Bouchard P; Toubert ME
Endocr Relat Cancer; 2007 Sep; 14(3):799-807. PubMed ID: 17914109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
